Results 161 to 170 of about 2,423,946 (178)
Some of the next articles are maybe not open access.

IgA nephropathy associated with anti-PLA2R antibody positive: a case report

International Urology and Nephrology, 2022
Qian Xiao, Qiu-yue Li
openaire   +1 more source

Anti‐PLA2R antibody in a secondary cause of membranous nephropathy

Nephrology, 2017
M. Hari Krishna Reddy   +4 more
openaire   +1 more source

Anti-PLA2R Antibody Levels and Treatment Response in Primary Membranous Nephropathy (MN)

Journal of the American Society of Nephrology, 2023
Anne-Els van de Logt   +2 more
openaire   +1 more source

“Voclosporin in late onset lupus nephritis with anti-PLA2R antibodies”

Seminars in Arthritis and Rheumatism
Ivana Capuano   +4 more
openaire   +3 more sources

Antibody–Drug Conjugates: Smart Chemotherapy Delivery Across Tumor Histologies

Ca-A Cancer Journal for Clinicians, 2022
Shanu Modi   +2 more
exaly  

The High-Throughput Approach Identifies Compounds that Block PLA2R and Anti-PLA2R Antibody Interaction

Journal of the American Society of Nephrology, 2023
Zixin Feng, Fusheng Guo, Zhao Cui
openaire   +1 more source

The role of anti-PLA2R antibody in membranous nephropathy diagnosis

Clinica Chimica Acta
M. Kurti   +3 more
openaire   +1 more source

Clinical Observation of Serum Anti-PLA2R Antibody Levels in the Treatment of Idiopathic Membranous Nephropathy with Rituximab

Journal of Clinical and Nursing Research
Objective: To investigate the efficacy of rituximab in the treatment of idiopathic membranous nephropathy with varying levels of serum phospholipase A2 receptor antibodies. Methods: A total of 137 patients with idiopathic membranous nephropathy admitted to Beijing Sixth Hospital were selected. Based on their blood PLA2R antibody levels before rituximab
openaire   +1 more source

Home - About - Disclaimer - Privacy